Lauren Averett Byers, professor of thoracic/head & neck medical oncology at the University of Texas MD Anderson Cancer Center, received the 2025 Edith and Peter O’Donnell Award in Medicine from the Texas Academy of Medicine, Engineering, Science and Technology. The award recognizes her fundamental discoveries and contributions to identifying novel therapeutic strategies for small cell lung cancer, which have paved the way for personalized treatments, even in the most highly recalcitrant cancers.
Giulio Draetta was recently named chief strategy officer at Orionis Biosciences, a privately held, clinical stage life sciences company focused on discovery, design, and development of precision medicines for cancer and immune system-related disorders. Orionis is based in Boston and Ghent, Belgium.
